GRACE, NCT05575804: GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer |
|
|
| Recruiting | 1/2 | 75 | RoW | GQ1001+pyrotinib, pyrotinib+capecitabine | Fudan University, GeneQuantum Healthcare (Suzhou) Co., Ltd. | Advanced/ Metastatic Her-2 Positive Breast Cancer | 01/25 | 01/25 | | |
